Published in J Biol Chem on December 26, 1997
Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J (2002) 2.39
Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep (2003) 2.21
Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88
Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep (2000) 1.72
Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol (1999) 1.59
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc Natl Acad Sci U S A (2005) 1.55
Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradation of stem-loop binding protein at the end of S phase. Mol Cell Biol (2008) 1.27
Arsenite-induced Cdc25C degradation is through the KEN-box and ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (2002) 1.26
Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs (2000) 1.24
Coordinate regulation of histone mRNA metabolism and DNA replication: cyclin A/cdk1 is involved in inactivation of histone mRNA metabolism and DNA replication at the end of S phase. Cell Cycle (2010) 0.94
Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage. Mol Cancer (2010) 0.87
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Mol Cancer (2008) 0.86
CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci. PLoS One (2013) 0.83
Mitotic phosphorylation of Cdc25B Ser321 disrupts 14-3-3 binding to the high affinity Ser323 site. J Biol Chem (2010) 0.83
The RNA Splicing Response to DNA Damage. Biomolecules (2015) 0.79
David and Goliath: chemical perturbation of eukaryotes by bacteria. J Ind Microbiol Biotechnol (2015) 0.75
A general framework for modeling growth and division of mammalian cells. BMC Syst Biol (2011) 0.75
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet (2000) 7.40
Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature (1998) 2.69
Distinct nuclear and spindle pole body population of cyclin-cdc2 in fission yeast. Nature (1990) 2.46
Dyskinetic cerebral palsy in Europe: trends in prevalence and severity. Arch Dis Child (2009) 2.17
Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun (1997) 1.99
p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene (1998) 1.76
Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene (1995) 1.59
Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry (1997) 1.49
Allosteric changes in the TCR/CD3 structure upon interaction with extra- or intra-cellular ligands. Scand J Immunol (2007) 1.43
Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry (1995) 1.35
Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene (1998) 1.31
Site-directed mutagenesis of the COOH-terminal region of colicin A: effect on secretion and voltage-dependent channel activity. Proc Natl Acad Sci U S A (1987) 1.23
Subcellular localisation of human wee1 kinase is regulated during the cell cycle. J Cell Sci (1995) 1.14
Individual domains of colicins confer specificity in colicin uptake, in pore-properties and in immunity requirement. J Mol Biol (1991) 1.14
The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaks. Oncogene (1999) 1.13
Variable rate of polypeptide chain elongation for colicins A, E2 and E3. J Mol Biol (1982) 1.13
Fission yeast Msp1 is a mitochondrial dynamin-related protein. J Cell Sci (1999) 1.13
Plasma membranes from rat intestinal epithelial cells at different stages of maturation. I. Preparation and characterization of plasma membrane subfractions originating from crypt cells and from villous cells. Biochim Biophys Acta (1978) 1.12
Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem (2001) 1.11
The membrane channel-forming colicin A: synthesis, secretion, structure, action and immunity. Biochim Biophys Acta (1988) 1.09
Regulation of CDC25B phosphatases subcellular localization. Oncogene (2000) 1.09
The European Perinatal Health Report: comparing the health and care of pregnant women and newborn babies in Europe. J Epidemiol Community Health (2009) 1.08
Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp Cell Res (2000) 1.04
Heterologous expression of the human cyclin-dependent kinase inhibitor p21Cip1 in the fission yeast, Schizosaccharomyces pombe reveals a role for PCNA in the chk1+ cell cycle checkpoint pathway. Mol Biol Cell (1996) 1.01
Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors. Oncogene (2011) 1.00
Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. Oncogene (2000) 0.99
Identification of a fission yeast dynamin-related protein involved in mitochondrial DNA maintenance. Biochem Biophys Res Commun (1998) 0.98
Cartographic study: breakpoints in 1574 families carrying human reciprocal translocations. Hum Genet (1996) 0.98
Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: involvement of the CDC25 phosphatase. Exp Cell Res (2000) 0.97
Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? Oncogene (1997) 0.96
Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR. Biochem Biophys Res Commun (2001) 0.96
Direct activation of cdc2 with phosphatase: identification of p13suc1-sensitive and insensitive steps. FEBS Lett (1990) 0.96
Viability thresholds for partial trisomies and monosomies. A study of 1,159 viable unbalanced reciprocal translocations. Hum Genet (1994) 0.95
G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress. Oncogene (2008) 0.94
Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells. J Biol Chem (2000) 0.94
Role of the fission yeast nim 1 protein kinase in the cell cycle response to nutritional signals. Biochem Biophys Res Commun (1997) 0.93
Trends in elective terminations of pregnancy between 1989 and 2000 in a French county (the Isère). Prenat Diagn (2003) 0.92
Secondary structure of the membrane-bound form of the pore-forming domain of colicin A. An attenuated total-reflection polarized Fourier-transform infrared spectroscopy study. Eur J Biochem (1991) 0.92
Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta. Mol Pharmacol (2005) 0.91
Case gender and severity in cerebral palsy varies with intrauterine growth. Arch Dis Child (2005) 0.91
Prevalence and time trends of disabilities in school-age children. Int J Epidemiol (1997) 0.89
Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors. Neuroscience (2008) 0.89
Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinase. FEBS Lett (2001) 0.89
Rare diseases in disabled children: an epidemiological survey. Arch Dis Child (2007) 0.88
Proteasome-dependent degradation of human CDC25B phosphatase. Mol Biol Rep (1999) 0.87
Predictive factors for an increased risk of sperm aneuploidies in oligo-astheno-teratozoospermic males. Int J Androl (2007) 0.87
Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells. FEBS Lett (1995) 0.86
Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene (2007) 0.85
A caspase-dependent cleavage of CDC25A generates an active fragment activating cyclin-dependent kinase 2 during apoptosis. Cell Death Differ (2008) 0.84
Conformation of colicin A: apparent difference between cytoplasmic and extracellular polypeptide chain. FEBS Lett (1987) 0.83
Efficacy of routine fetal ultrasound screening for congenital heart disease in Isère County, France. Prenat Diagn (1999) 0.83
Purification and reconstitution into liposomes of an integral membrane protein conferring immunity to colicin A. FEMS Microbiol Lett (1989) 0.82
Uptake across the cell envelope and insertion into the inner membrane of ion channel-forming colicins in E coli. Biochimie (1990) 0.82
Use of CDC2 from etoposide-treated cells as substrate to assay CDC25 phosphatase activity. Anticancer Res (1999) 0.82
Effects of phleomycin-induced DNA damage on the fission yeast Schizosaccharomyces pombe cell cycle. Yeast (1995) 0.81
Interactions of colicin A domains with phospholipid monolayers and liposomes: relevance to the mechanism of action. Biochemistry (1989) 0.81
Visual impairment in children: prevalence, aetiology and care, 1976-85. Paediatr Perinat Epidemiol (1998) 0.81
Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro. Biochem J (1999) 0.81
Recombinant and chemical derivatives of apamin. Implication of post-transcriptional C-terminal amidation of apamin in biological activity. Eur J Biochem (1995) 0.80
Use of the two-hybrid system to identify protein-protein interaction temperature-sensitive mutants: application to the CDK2/p21Cip1 interaction. Nucleic Acids Res (1997) 0.79
Effect of phenylarsine oxide on the fission yeast Schizosaccharomyces pombe cell cycle. Biochimie (1995) 0.78
[Epidemiology of respiratory allergy in children]. Arch Pediatr (1999) 0.78
[Impact on parents of cerebral palsy in children: a literature review]. Arch Pediatr (2010) 0.78
[How to calculate the completeness of ascertainment of a morbidity register? Example of the Isere childhood handicap register in Grenoble, France]. Rev Epidemiol Sante Publique (2000) 0.78
Doxorubicin promotes transcriptional upregulation of Cdc25B in cancer cells by releasing Sp1 from the promoter. Oncogene (2012) 0.78
Synthesis and sequence-specific proteolysis of a hybrid protein (colicin A::growth hormone releasing factor) produced in Escherichia coli. Gene (1989) 0.77
Characterisation of human cdc2 lysine 33 mutations expressed in the fission yeast Schizosaccharomyces pombe. FEBS Lett (1996) 0.77
Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonance. FEBS Lett (1996) 0.77
cdc2 protein kinase: interactions with cyclins and suc1. Cold Spring Harb Symp Quant Biol (1991) 0.76
[Epidemiology and clinical characteristics of childhood parapneumonic empyemas]. Arch Pediatr (2007) 0.76
[Human familial autosomal reciprocal translocations]. Ann Genet (1995) 0.76
Colicin A lysis protein promotes extracellular release of active human growth hormone accumulated in Escherichia coli cytoplasm. Biochimie (1993) 0.76
Human reciprocal translocations: a new computer system for genetic counseling. Ann Genet (1992) 0.76
Microtubule cytoskeleton and morphogenesis in the amoebae of the myxomycete Physarum polycephalum. Biol Cell (1988) 0.76
[Cytomegalovirus infection in pregnant women. Seroepidemiological prospective study in 1,018 women in Isere]. J Gynecol Obstet Biol Reprod (Paris) (1998) 0.76
Interaction between the fission yeast nim1/cdr1 protein kinase and a dynamin-related protein. FEBS Lett (1999) 0.76
Prevalence, aetiology, and care of severe and profound hearing loss. Arch Dis Child (1996) 0.75
[Cytomegalovirus infections at birth: what frequency?]. Presse Med (1997) 0.75
[Evaluation of maternal morbidity after drug-induced termination of pregnancy (TOP) after 12 gestation weeks]. J Gynecol Obstet Biol Reprod (Paris) (2003) 0.75
Photoaffinity labeling of membrane-bound porcine aminopeptidase N. Biochim Biophys Acta (1982) 0.75
[Feasibility of the foetal alcool syndrome surveillance]. Arch Pediatr (2008) 0.75
[Role of CDC25 phosphatases in the control of proliferation]. Pathol Biol (Paris) (2000) 0.75
Prevalence and characteristics of children with mild intellectual disability in a French county. J Intellect Disabil Res (2013) 0.75
[Combined use of nuchal translucency, gestational age and maternal age for evaluation of the risk of trisomy 21]. J Gynecol Obstet Biol Reprod (Paris) (1999) 0.75
[An epidemic of cholera in the city of Pemba (Mozambique) in 1983]. Rev Epidemiol Sante Publique (1986) 0.75
A set of beta-galactosidase gene fusion cassettes demonstrates usefulness in expressing HIV-1 genes in Escherichia coli. Plasmid (1994) 0.75
The fission yeast Nim1/Cdr1 kinase: a link between nutritional state and cell cycle control. Prog Cell Cycle Res (1995) 0.75
[Preterm births circumstances in babies born before 35 weeks in French Alpes: PREMALP study]. J Gynecol Obstet Biol Reprod (Paris) (2010) 0.75
[Cross-sectional study of school integration of asthmatic children in a general population sample]. Arch Pediatr (2000) 0.75
[Definition and prevalence of school-age multi-handicaps]. Arch Pediatr (1998) 0.75
Evidence for a mammalian Nim1-like kinase pathway acting at the G0-1/S transition. Biochem Biophys Res Commun (1997) 0.75
[Role of "subtle" ultrasonographic signs during antenatal screening for trisomy 21 during the second trimester of pregnancy: meta-analysis and CPDPN protocol of the Grenoble University Hospital]. J Gynecol Obstet Biol Reprod (Paris) (2005) 0.75